H. Cui

发表

Angiogenic and Arthritogenic Properties of the Soluble Form of CD13

A. Urquhart, Chenyang Lu, J. Lawton, 2019, The Journal of Immunology.

In Vivo Mechanisms of Tissue-Selective Drug Toxicity: Effects of Liver-Specific Knockout of the NADPH-Cytochrome P450 Reductase Gene on Acetaminophen Toxicity in Kidney, Lung, and Nasal Mucosa

H. Cui, Qing-Yu Zhang, M. Behr, 2005, Molecular Pharmacology.

Design, synthesis, and biological evaluation of bifunctional thyrointegrin inhibitors: new anti-angiogenesis analogs

S. Mousa, E. Dyskin, A. Bridoux, 2011, Journal of enzyme inhibition and medicinal chemistry.

Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.

S. Mousa, M. Yalçın, E. Dyskin, 2009, Bioorganic & medicinal chemistry letters.

Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

S. Mousa, V. Adhami, H. Mukhtar, 2009, Cancer research.

Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer.

S. Mousa, B. Mian, D. Bharali, 2017, Nanomedicine : nanotechnology, biology, and medicine.

CD318 is a ligand for CD6

M. Moasser, Benlian Wang, A. Zijlstra, 2017, Proceedings of the National Academy of Sciences.

Min-Effect of dietary zinc pectin oligosaccharides chelate on growth performance, enzyme activities, Zn accumulation, metallothionein concentration, and gene expression of Zn transporters in broiler chickens

H. Cui, Hao Nie, Xiulan Gao, 2019 .

Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin.

S. Mousa, J. Veith, M. Yalçın, 2011, Anticancer research.

Effects of Obesity and Sex on Antimicrobial Pharmacokinetics and Acute Kidney Injury: Validation of a Preclinical Model

S. Mousa, H. Cui, Adinoyi O. Garba, 2012, Antimicrobial Agents and Chemotherapy.

Transgenic Mice with a Hypomorphic NADPH-Cytochrome P450 Reductase Gene: Effects on Development, Reproduction, and Microsomal Cytochrome P450

P. Swiatek, L. Kaminsky, H. Cui, 2005, Journal of Pharmacology and Experimental Therapeutics.

Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer

S. Mousa, D. Bharali, H. Cui, 2015, Pharmaceutical Research.

Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene

H. Cui, Qing-Yu Zhang, Y. Weng, 2003, Journal of Biological Chemistry.

Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.

S. Mousa, V. Adhami, H. Mukhtar, 2012, Carcinogenesis.

Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus.

Brian E. Smith, S. Mousa, S. Georas, 2013, Prostaglandins, leukotrienes, and essential fatty acids.

Targeted Disruption of the Olfactory Mucosa-Specific Cyp2g1 Gene: Impact on Acetaminophen Toxicity in the Lateral Nasal Gland, and Tissue-Selective Effects on Cyp2a5 Expression

P. Swiatek, H. Cui, Qing-Yu Zhang, 2004, Journal of Pharmacology and Experimental Therapeutics.

Award Number: W81XWH-10-1-0245 TITLE: Sustained Release Oral Nanoformulated Green Tea for Prostate Cancer Prevention PRINCIPAL INVESTIGATOR: Hasan Mukhtar, Ph.D. CONTRACTING ORGANIZATION: University of Wisconsin System Board of Regents

S. Mousa, V. Adhami, H. Mukhtar, 2013 .

Aspirin resistance in young men with Type 2 diabetes

Subhashini Yaturu, Emmy Dier, Huadong Cui, 2014 .

Generation and characterization of a transgenic mouse model with hepatic expression of human CYP2A6.

P. Swiatek, H. Cui, Qing-Yu Zhang, 2005, Biochemical and biophysical research communications.

Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer

S. Mousa, D. Bharali, H. Cui, 2015, Pharmaceutical Research.

Thymoquinone Modulates Blood Coagulation in Vitro via Its Effects on Inflammatory and Coagulation Pathways

S. Mousa, H. Cui, Jaehan Kim, 2016, International journal of molecular sciences.

Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.

S. Mousa, V. Adhami, H. Mukhtar, 2012, Carcinogenesis.